Impact of gender on event rates at 1-year in patients with newly diagnosed non-valvular atrial fibrillation: Contemporary perspective from the GARFIELD-AF registry

Keyphrases

• 1-year Outcome 16%
• All-cause Mortality 50%
• Anticoagulant Treatment 83%
• Anticoagulants 100%
• Antiplatelet 16%
• Antithrombotic Therapy 16%
• Atrial Fibrillation 100%
• Baseline Risk 16%
• Contemporary Perspective 100%
• Event Rate 100%
• Healthcare Settings 16%
• High Risk 16%
• Major Bleeding 50%
• Mortality Reduction 16%
• Newly Diagnosed 100%
• Non-interventional 16%
• Non-valvular Atrial Fibrillation 100%
• Poisson Model 16%
• Risk Factors 16%
• Stroke Risk 16%
• Stroke Risk Factors 16%
• Systemic Embolism 83%
• Treatment Patterns 16%
• Untreated Patients 16%

Nursing and Health Professions

• All Cause Mortality 42%
• Anticoagulant Agent 100%
• Anticoagulant Therapy 71%
• Atrial Fibrillation 100%
• Bleeding 28%
• Cerebrovascular Accident 85%
• Mortality Rate 14%

Pharmacology, Toxicology and Pharmaceutical Science

• All Cause Mortality 25%
• Anticoagulant Agent 100%
• Antiplatelet 8%
• Atrial Fibrillation 100%
• Bleeding 16%
• Cerebrovascular Accident 50%
• Mortality Rate 8%